Evidence map›Paper›PMID 36976180›Full record

ArticleThe Journal of experimental medicine2023

Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes.

Stephan Culemann, Katharina Knab, Maximilien Euler, Anja Wegner, Hilal Garibagaoglu, Jochen Ackermann, Kim Fischer, Deborah Kienhöfer, Georgiana Crainiciuc, Jonas Hahn and 7 more

Erratum issuedAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Recruitment of CCR5Genes and immunity · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Stephan Culemann *Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0000-0001-9837-2811
Katharina Knab *Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0009-0001-0533-7214
Maximilien Euler *Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0000-0003-4009-1640
Anja WegnerDepartment of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0000-0003-0086-2498
Hilal GaribagaogluDepartment of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0000-0001-7673-7330
Jochen AckermannDepartment of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0009-0009-1922-0306
Kim FischerDepartment of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0000-0002-4253-636X
Deborah KienhöferDepartment of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0009-0001-4082-8377
Georgiana CrainiciucArea of Cell and Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III , Madrid, Spain.ORCID 0000-0002-0912-7425
Jonas HahnDepartment of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0000-0003-3944-2108
Anika GrüneboomDepartment of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0000-0002-7928-5613
Falk NimmerjahnInstitute of Genetics at the Department of Biology, Friedrich-Alexander University Erlangen-Nürnberg , Erlangen, Germany.ORCID 0000-0002-5418-316X
Stefan UderhardtDepartment of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0000-0002-2489-2109
Andrés HidalgoArea of Cell and Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III , Madrid, Spain.ORCID 0000-0001-5513-555X
Georg SchettDepartment of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0000-0001-8740-9615
Markus H Hoffmann *Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0000-0001-9698-9922
Gerhard Krönke *Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen , Erlangen, Germany.ORCID 0000-0002-7566-4325

Funding

Non-canonical functions of neutrophilsR01AI165661 · NIAID · YALE UNIVERSITY · PI HIDALGO, ANDRES · 2022 to 2025
$2.8M
European Research Council 101001866European Research Council 810316NIAID NIH HHS R01 AI165661
6 · The paper itself

Abstract

Clodronate liposomes (Clo-Lip) have been widely used to deplete mononuclear phagocytes (MoPh) to study the function of these cells in vivo. Here, we revisited the effects of Clo-Lip together with genetic models of MoPh deficiency, revealing that Clo-Lip exert their anti-inflammatory effects independent of MoPh. Notably, not only MoPh but also polymorphonuclear neutrophils (PMN) ingested Clo-Lip in vivo, which resulted in their functional arrest. Adoptive transfer of PMN, but not of MoPh, reversed the anti-inflammatory effects of Clo-Lip treatment, indicating that stunning of PMN rather than depletion of MoPh accounts for the anti-inflammatory effects of Clo-Lip in vivo. Our data highlight the need for a critical revision of the current literature on the role of MoPh in inflammation.

Indexed as

Clodronic AcidLiposomesAnti-Inflammatory AgentsHumansInflammationNeutrophilsAnti-Inflammatory AgentsClodronic AcidLiposomes

Identifiers

PMID36976180
PMCPMC10067541

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.